These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33641639)

  • 1. Neuroimaging changes associated with vitamin D Deficiency - a narrative review.
    Sultan S
    Nutr Neurosci; 2022 Aug; 25(8):1650-1658. PubMed ID: 33641639
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms.
    Soares JZ; Pettersen R; Benth JŠ; Persson K; Strobel C; Selbæk G; Bogdanovic N
    J Alzheimers Dis; 2021; 79(1):311-321. PubMed ID: 33252081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.
    Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA;
    Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of vitamin D deficiency with MRI markers of brain health in a community sample.
    Croll PH; Boelens M; Vernooij MW; van de Rest O; Zillikens MC; Ikram MA; Voortman T
    Clin Nutr; 2021 Jan; 40(1):72-78. PubMed ID: 32387186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
    Frodl T; Amico F
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():295-303. PubMed ID: 23313563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency is associated with reduced hippocampal volume and disrupted structural connectivity in patients with mild cognitive impairment.
    Al-Amin M; Bradford D; Sullivan RKP; Kurniawan ND; Moon Y; Han SH; Zalesky A; Burne THJ
    Hum Brain Mapp; 2019 Feb; 40(2):394-406. PubMed ID: 30251770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D, cognitive dysfunction and dementia in older adults.
    Dickens AP; Lang IA; Langa KM; Kos K; Llewellyn DJ
    CNS Drugs; 2011 Aug; 25(8):629-39. PubMed ID: 21790207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative D3 vitamin deficiency and consequent cognitive impairment in an animal model of Alzheimer's disease: Potential involvement of collapsin response mediator protein-2.
    Lin FY; Lin YF; Lin YS; Yang CM; Wang CC; Hsiao YH
    Neuropharmacology; 2020 Mar; 164():107910. PubMed ID: 31838171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment.
    Zhu W; Huang H; Yang S; Luo X; Zhu W; Xu S; Meng Q; Zuo C; Liu Y; Wang W;
    Neurosci Bull; 2021 Jun; 37(6):789-803. PubMed ID: 33826095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASSOCIATION OF VITAMIN D WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DEMENTIA IN OLDER MEXICAN ADULTS.
    Aguilar-Navarro SG; Mimenza-Alvarado AJ; Jiménez-Castillo GA; Bracho-Vela LA; Yeverino-Castro SG; Ávila-Funes JA
    Rev Invest Clin; 2019; 71(6):381-386. PubMed ID: 31823966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Serum 25-Hydroxyvitamin D Level and Cognitive Impairment in Patients with White Matter Lesions: A Cross-Sectional Study.
    Wang L; Zhao XM; Yuan XZ; Wang FY; Shen J; Wang Y
    Med Princ Pract; 2020; 29(5):451-457. PubMed ID: 32126568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of white matter hyperintensities with low serum 25-hydroxyvitamin D levels.
    Prager JM; Thomas C; Ankenbrandt WJ; Meyer JR; Gao Y; Ragin A; Sidharthan S; Hutten R; Wu YG
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1145-9. PubMed ID: 24436348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and Dementia.
    Littlejohns TJ; Kos K; Henley WE; Kuźma E; Llewellyn DJ
    J Prev Alzheimers Dis; 2016; 3(1):43-52. PubMed ID: 29214280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
    Hall JM; Lewis SJG
    Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.